Is JWCTF or RYLD a better dividend investment in 2026?

JWCTF currently yields 651.47% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: JWCTF offers higher current income.

What is the dividend yield difference between JWCTF and RYLD?

JWCTF has a forward dividend yield of 651.47% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 639.33 percentage points.

Home › Compare › JWCTF vs RYLD

JWCTF vs RYLD: Dividend Comparison 2026

JWCTF yields 651.47% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 JWCTF wins by $503577.86M in total portfolio value

INVESTMENT

TIME HORIZON10 years

JWCTF

● Live price

651.47%

Share price

$0.31

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$503577.90M

Annual income

$386,785,137,245.59

Full JWCTF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — JWCTF vs RYLD

📍 JWCTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	JWCTF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, JWCTF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

JWCTF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

JWCTF

Annual income on $10K today (after 15% tax)

$55,374.59/yr

After 10yr DRIP, annual income (after tax)

$328,767,366,658.75/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, JWCTF beats the other by $328,767,364,459.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of JWCTF + RYLD for your $10,000?

JWCTF: 50%RYLD: 50%

100% RYLD50/50100% JWCTF

Portfolio after 10yr

$251788.97M

Annual income

$193,392,569,916.46/yr

Blended yield

76.81%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

JWCTF buys

RYLD buys

No recent congressional trades found for JWCTF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricJWCTFRYLD

Forward yield	651.47% ✓	12.14%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$503577.90M ✓	$44.5K
Annual income after 10y	$386,785,137,245.59 ✓	$2,587.35
Total dividends collected	$493990.56M ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: JWCTF vs RYLD ($10,000, DRIP)

Year	JWCTF Portfolio	JWCTF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$75,847	$65,146.58	$11,914	$1,213.65	+$63.9K → JWCTF
2	$542,945	$461,789.28	$14,099	$1,351.30	+$528.8K → JWCTF
3	$3,670,393	$3,089,441.65	$16,580	$1,494.55	+$3.65M → JWCTF
4	$23,446,108	$19,518,787.95	$19,384	$1,642.61	+$23.43M → JWCTF
5	$141,614,527	$116,527,191.03	$22,535	$1,794.70	+$141.59M → JWCTF
6	$809,307,352	$657,779,808.21	$26,063	$1,950.00	+$809.28M → JWCTF
7	$4,379,155,354	$3,513,196,486.95	$29,995	$2,107.69	+$4379.13M → JWCTF
8	$22,451,936,399	$17,766,240,170.59	$34,361	$2,266.99	+$22451.90M → JWCTF
9	$109,152,115,265	$85,128,543,318.27	$39,194	$2,427.12	+$109152.08M → JWCTF
10	$503,577,900,579	$386,785,137,245.59	$44,525	$2,587.35	+$503577.86M → JWCTF

JWCTF vs RYLD: Complete Analysis 2026

JWCTF — Stock

JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, the People's Republic of China.

Full JWCTF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this JWCTF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

JWCTF vs SCHD JWCTF vs JEPI JWCTF vs O JWCTF vs KO JWCTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.